Anaemia of pregnancy – Diagnostics – Overview of Information and Clinical Research

Anaemia of pregnancy happens when your blood doesn’t have enough healthy red blood cells to carry oxygen to you and your growing baby. This is one of the most common conditions during pregnancy, affecting millions of women worldwide, and while mild cases are often normal due to the natural increase in blood volume, proper diagnosis and treatment are essential for your health and your baby’s development.

Introduction: Who Should Undergo Diagnostics

Every pregnant woman should be tested for anaemia as part of routine prenatal care. When you become pregnant, your body undergoes remarkable changes, including producing 20% to 30% more blood to support your growing baby. This natural increase in blood volume means your body needs significantly more iron, folic acid, and vitamin B12 to make enough healthy red blood cells. Without these nutrients in sufficient amounts, you can develop anaemia, which affects how oxygen reaches your organs and your developing baby.^[1]

Testing for anaemia is particularly important at your first prenatal visit because early detection allows for timely treatment before complications develop. Your healthcare provider will typically screen you again during the later part of your second trimester to check if your iron levels remain adequate as pregnancy progresses. This is crucial because your baby’s demand for nutrients increases dramatically during the second and third trimesters, and even women who had normal iron stores at the beginning of pregnancy can become anaemic as the pregnancy advances.^[2]

Certain groups of pregnant women face higher risk and may need more frequent monitoring. If you are pregnant with twins or more, your body needs to produce even more blood, putting extra strain on your iron reserves. Women who experience severe morning sickness and vomit frequently may struggle to keep down iron-rich foods and supplements, increasing their risk. If you have two pregnancies close together, your body may not have had enough time to rebuild its iron stores from the previous pregnancy. Additionally, if you had heavy menstrual periods before becoming pregnant, you may have started pregnancy with already depleted iron reserves.^[1]

You should seek diagnostic testing promptly if you notice symptoms that might indicate anaemia. These warning signs include persistent fatigue that doesn’t improve with rest, feeling unusually weak or dizzy, experiencing shortness of breath with minimal activity, or noticing that your skin, lips, or nails appear pale. Some women develop unusual cravings for non-food items such as ice, dirt, or chalk, which can signal iron deficiency. A rapid or irregular heartbeat, frequent headaches, or difficulty concentrating are also reasons to contact your healthcare provider for evaluation.^[1]

⚠️ Important

Many symptoms of anaemia overlap with normal pregnancy discomforts such as tiredness and feeling weak. Because of this similarity, you might dismiss important warning signs as simply being part of pregnancy. This is why routine blood testing at prenatal appointments is essential, even if you feel relatively well. Many women with anaemia have no obvious symptoms, especially in the early stages, and the condition is only detected through blood tests.

Women who follow strict vegetarian or vegan diets should be particularly attentive to anaemia screening. If you don’t eat meat, poultry, or fish, you may be at greater risk for iron deficiency because the form of iron found in plant foods is harder for your body to absorb compared to the iron in animal products. Vegans who consume no animal products at all, including dairy and eggs, also face increased risk of vitamin B12 deficiency, as this nutrient is primarily found in foods from animal sources.^[3]

If you are a teenager who becomes pregnant, your risk for anaemia is higher because your body is still growing and developing itself. This means you need nutrients not only for your baby but also to support your own continued physical development. Similarly, women with certain chronic health conditions such as celiac disease or Crohn’s disease, or those who have had weight loss surgery, may have difficulty absorbing nutrients properly and should undergo careful monitoring throughout pregnancy.^[3]

Classic Diagnostic Methods

The primary test used to diagnose anaemia during pregnancy is called a complete blood count, often shortened to CBC. This is a straightforward blood test that provides detailed information about the different types of cells in your blood, including red blood cells. During this test, a healthcare professional draws a small amount of blood from a vein in your arm, usually during one of your routine prenatal appointments. The sample is then sent to a laboratory where specialized equipment counts and analyzes your blood cells.^[1]

The complete blood count measures several important values that help doctors identify anaemia. The most crucial measurement is your hemoglobin level, which tells doctors how much of the oxygen-carrying protein you have in your red blood cells. Healthcare providers also look at your hematocrit, which represents the percentage of your blood volume made up of red blood cells. During pregnancy, these values naturally decrease somewhat because of the increase in blood volume, but they should not fall below certain thresholds.^[1]

Specific hemoglobin levels define whether you have anaemia at different stages of pregnancy. During your first trimester, anaemia is diagnosed if your hemoglobin falls below 11 grams per deciliter or your hematocrit drops below 33%. In the second trimester, the threshold is slightly lower because blood volume increases most dramatically during this period—hemoglobin below 10.5 grams per deciliter or hematocrit below 32% indicates anaemia. By the third trimester, the diagnostic criteria return to the same levels as the first trimester: hemoglobin below 11 grams per deciliter or hematocrit below 33%.^[14]

Another important value from the complete blood count is the mean corpuscular volume, abbreviated as MCV. This measurement tells doctors the average size of your red blood cells. When the MCV is low, meaning your red blood cells are smaller than normal, this typically suggests iron deficiency anaemia. When the MCV is high, indicating larger-than-normal red blood cells, this may point toward deficiencies in folic acid or vitamin B12. This information helps your healthcare provider understand what type of anaemia you have and guides decisions about further testing and treatment.^[14]

If your initial complete blood count shows anaemia, your doctor will likely order additional tests to determine the specific cause. For suspected iron deficiency, the most accurate test measures your serum ferritin level. Ferritin is a protein that stores iron in your body, and measuring it reveals how much iron you have in reserve. This test has the highest accuracy for diagnosing iron deficiency unless you also have an infection or inflammatory condition, which can make the results harder to interpret.^[17]

To distinguish between different types of anaemia, doctors may order tests that measure specific nutrients in your blood. A serum folate test checks your folic acid levels, while a vitamin B12 blood test reveals whether you have adequate amounts of this essential nutrient. These are particularly important if your mean corpuscular volume suggests you have large red blood cells, which often indicates a deficiency in one of these vitamins.^[14]

In some cases, your doctor may recommend hemoglobin electrophoresis, a specialized test that analyzes the different types of hemoglobin in your blood. This test is important for identifying inherited blood disorders such as sickle cell disease or thalassemia, which can also cause anaemia during pregnancy. These conditions affect how your body makes hemoglobin and require different management approaches than nutritional deficiencies. Women with a family history of these disorders or those from certain ethnic backgrounds where these conditions are more common may undergo this testing early in pregnancy or even before conception.^[14]

⚠️ Important

The timing of anaemia screening matters significantly. Your healthcare provider typically tests your blood at your first prenatal visit to establish a baseline and identify any existing deficiencies. Testing is often repeated during the late second trimester, around weeks 24 to 28 of pregnancy, because this is when iron demands increase substantially and even women who started pregnancy with adequate stores may become anaemic. Some providers also test again in the third trimester to ensure iron levels remain sufficient as you approach delivery.

If your diagnostic tests reveal anaemia but the cause remains unclear after initial evaluation, or if your anaemia is particularly severe or doesn’t respond to standard treatment, your obstetrician may refer you to a hematologist. This is a doctor who specializes in blood disorders and can perform more advanced diagnostic procedures. They may conduct additional specialized tests to identify rare causes of anaemia or evaluate whether you have multiple contributing factors affecting your red blood cell production.^[2]

Throughout pregnancy, your healthcare provider may repeat blood tests periodically to monitor how well treatment is working if you’ve been diagnosed with anaemia. These follow-up tests help ensure that your iron supplementation or other interventions are raising your hemoglobin and hematocrit to healthy levels. Regular monitoring is particularly important because untreated or inadequately treated anaemia can lead to complications for both you and your baby, including increased risk of preterm delivery, low birth weight, and developmental concerns.^[2]

After delivery, your doctor may recommend checking your blood counts again, typically around 4 to 6 weeks postpartum. This is especially important if you lost significant blood during delivery or if you were anaemic during pregnancy. Postpartum anaemia is defined as hemoglobin below 10 grams per deciliter after childbirth, and it can affect your recovery, milk production if you’re breastfeeding, and your overall energy level as you care for your newborn.^[2]

Diagnostics for Clinical Trial Qualification

Clinical trials investigating treatments for anaemia during pregnancy use standardized diagnostic criteria to determine which participants can enroll. These studies typically require documentation of anaemia through a complete blood count showing hemoglobin levels below the established thresholds for pregnancy. Researchers use the same diagnostic definitions applied in routine clinical care, with hemoglobin below 11 grams per deciliter in the first and third trimesters or below 10.5 grams per deciliter in the second trimester serving as the primary qualification criterion.^[13]

Beyond confirming the presence of anaemia, clinical trials often require additional testing to identify the specific type and cause. Most studies focused on iron deficiency anaemia require proof of low iron stores through serum ferritin testing. Because ferritin is the most sensitive and specific marker for diagnosing iron deficiency in pregnancy, trial protocols typically set a specific ferritin threshold that participants must meet for inclusion. This ensures that the study examines treatments in the population most likely to benefit from iron-specific interventions.^[17]

The timing of diagnosis relative to pregnancy stage is often a critical factor in trial enrollment. Many research studies specifically recruit women early in their second trimester because this represents an optimal window for intervention. Iron requirements increase substantially during this period, and treating anaemia at this stage may prevent complications later in pregnancy. A recent large study in India, for example, enrolled participants who were identified with moderate anaemia and iron deficiency before 17 weeks of gestation, allowing researchers to evaluate whether early intervention improved outcomes compared to standard care.^[12]

Clinical trials comparing different treatment approaches require comprehensive baseline testing to characterize participants’ anaemia severity and distinguish between those with mild, moderate, or severe disease. The World Health Organization classifies anaemia severity based on hemoglobin levels: mild anaemia ranges from 10 to 10.9 grams per deciliter, moderate anaemia from 7 to 9.9 grams per deciliter, and severe anaemia is defined as hemoglobin below 7 grams per deciliter. Research protocols may limit enrollment to specific severity categories depending on the treatments being studied and the research questions being addressed.^[13]

Studies evaluating intravenous iron treatments often have additional diagnostic requirements. Because these interventions are typically reserved for women who cannot tolerate oral iron supplements or have persistent anaemia despite oral treatment, trial protocols may require documentation of previous treatment failure or intolerance. Participants might need to demonstrate either lack of hemoglobin improvement after a specified period of oral iron supplementation or documented side effects that prevented them from continuing oral therapy.^[12]

Some clinical trials exclude participants with certain other medical conditions that could affect how anaemia is diagnosed or treated. For example, studies might exclude women with inherited blood disorders like sickle cell disease or thalassemia because these conditions cause anaemia through different mechanisms than nutritional deficiencies. Similarly, women with active infections or inflammatory conditions might be excluded because these can interfere with serum ferritin measurements and make it difficult to accurately assess iron status.^[17]

Follow-up diagnostic procedures during clinical trials typically include regular complete blood counts to monitor changes in hemoglobin and hematocrit levels over time. Researchers measure these values at specific intervals—often monthly or at designated gestational ages—to track how effectively different treatments raise red blood cell levels. These repeated measurements help determine not only whether a treatment works but also how quickly it produces results and whether benefits are sustained throughout pregnancy.^[12]

Clinical trials investigating anaemia treatments also track important pregnancy outcomes that require their own diagnostic assessments. Researchers monitor for preterm delivery, defined as birth before 37 completed weeks of pregnancy, using standard obstetric dating methods based on ultrasound or last menstrual period. They track infant birth weight at delivery to identify babies born with low birth weight, typically defined as less than 2,500 grams. These outcome measures help researchers understand whether treating maternal anaemia prevents complications for babies.^[12]

Some research protocols include additional specialized diagnostic tests not routinely performed in standard prenatal care. These might include more detailed iron studies beyond basic ferritin levels, such as transferrin saturation or total iron-binding capacity, which provide comprehensive information about how iron moves through and is stored in your body. While these tests offer valuable research data, they are not typically necessary for clinical diagnosis and treatment outside of research settings.^[13]

Postpartum diagnostic assessments form an important component of many clinical trials studying anaemia in pregnancy. Researchers follow participants after delivery to check hemoglobin levels, monitor for postpartum anaemia, and track whether babies develop anaemia in early infancy. This extended follow-up period helps researchers understand the long-term effects of different treatment approaches initiated during pregnancy and whether benefits persist after childbirth.^[2]

Prognosis and Survival Rate

Prognosis

The outlook for women with anaemia during pregnancy is generally very good when the condition is identified early and treated appropriately. Mild anaemia is common during pregnancy due to the natural increase in blood volume, and most cases respond well to dietary changes and iron supplementation. With proper treatment, hemoglobin levels typically improve within several weeks, and many women experience relief from symptoms such as fatigue and weakness as their red blood cell counts rise.^[1]

However, the prognosis depends significantly on whether anaemia is detected and treated or left untreated. Severe untreated anaemia during pregnancy increases the risk of several complications that affect both mother and baby. For the mother, untreated anaemia raises the risk of needing blood transfusions during or after delivery and makes fighting infections more difficult. It can also increase the likelihood of developing postpartum depression after the baby is born. For the developing baby, maternal anaemia—particularly if severe during the first two trimesters—is associated with increased risk of preterm delivery, meaning birth before 37 completed weeks of pregnancy. Babies born to mothers with untreated anaemia are also more likely to have low birth weight and may be at higher risk of being born with anaemia themselves, which can lead to developmental problems.^[2]

The type and cause of anaemia influence prognosis as well. Iron deficiency anaemia, the most common form during pregnancy, typically has an excellent prognosis when treated with iron supplements and dietary modifications. Folate deficiency anaemia also responds well to supplementation. Vitamin B12 deficiency may require ongoing treatment, especially for women who follow strict vegan diets, but can be effectively managed with supplements or injections. In contrast, anaemia caused by inherited blood disorders such as sickle cell disease or thalassemia requires more specialized management throughout pregnancy.^[1]

Long-term outcomes for babies born to mothers with treated anaemia are generally positive. When maternal anaemia is corrected during pregnancy, babies typically develop normally without lasting effects. However, babies born to mothers with severe untreated anaemia, particularly during the first trimester when crucial early development occurs, may face increased risk of developmental concerns that can affect learning and growth. This underscores the importance of early detection and treatment in protecting your baby’s long-term health.^[1]

Recovery after delivery is an important aspect of prognosis for women who were anaemic during pregnancy. Most women’s blood counts improve in the weeks following childbirth as blood volume returns to pre-pregnancy levels. However, women who experienced significant blood loss during delivery or who were already severely anaemic may take longer to recover. Postpartum anaemia can affect energy levels, mood, and the ability to care for a newborn, making follow-up testing and continued treatment important in the weeks after delivery.^[2]

Survival rate

In developed countries with access to modern medical care, mortality directly related to anaemia during pregnancy is extremely rare. The vast majority of pregnant women with anaemia, even in moderate to severe cases, survive pregnancy and childbirth without life-threatening complications when they receive appropriate prenatal care and treatment. The routine screening programs and treatment protocols available in healthcare systems in developed nations have made death from pregnancy-related anaemia uncommon.^[8]

However, anaemia remains a significant global public health problem in low- and lower-middle income countries where the condition is more prevalent and access to healthcare may be limited. Worldwide, an estimated 37% of pregnant women are affected by anaemia according to the World Health Organization. In developing countries, particularly in regions of Africa and South-East Asia, iron deficiency affects up to 52% of pregnant women. In these settings with limited healthcare resources, severe untreated anaemia can contribute to maternal mortality, though exact survival statistics specifically attributable to anaemia are difficult to isolate because the condition often occurs alongside other complications.^[1]^[8]

For babies, the impact of maternal anaemia on survival depends on severity and timing. Severe maternal anaemia increases the risk of stillbirth, which means the baby dies before birth, and some studies show a higher risk of infant death immediately before or after birth when mothers have severe iron deficiency anaemia. However, with appropriate treatment of maternal anaemia during pregnancy, infant survival rates are not significantly different from pregnancies without anaemia. This highlights how effective treatment can eliminate most serious risks to babies.^[5]

The prognosis has improved dramatically over time due to better understanding of anaemia’s causes and effects during pregnancy, along with the implementation of widespread screening programs and availability of effective treatments. In settings where pregnant women receive regular prenatal care including routine blood testing, iron supplementation, and nutritional guidance, anaemia is detected early when it’s most treatable, making serious outcomes extremely uncommon.^[2]

#1 Clinical Trials Search in Europe